Longevity/mortality Buy-Ins, Buy-Outs, Longevity Bonds, Pandemics

Analysis

German life book consolidation: cultural shift needed

Following the sale of Generali Leben to Viridium, the largest-ever transfer of a German life book, participants are hopeful it will convince doubtful minds and open the door to more deals. Christopher Cundy reports

Equity release mortgages: stopping the roof falling in

The Prudential Regulation Authority has shaken up life insurers by proposing new assumptions around the valuation of ERMs. The more prudent approach seeks to avoid a potential disaster if house prices stagnate or crash, but the impact on insurers could be serious. Christopher Cundy reports

The PRA's David Rule on Brexit, the risk margin and the regulator's hotspots for supervision in 2018

The UK's executive director for insurance supervision talks to Christopher Cundy about how the Prudential Regulation Authority is approaching Brexit and reveals the latest views on reforming the risk margin

Lapse risk takes centre stage in capital management strategies

Since the introduction of Solvency II, EU life insurers have had to hold much more capital against the risk of customers lapsing their policies. Luca Tres explains how innovative hedging structures can help firms maximise their capital efficiency

Swiss Re's Dan Ryan: UK moratorium on genetic testing will have to change

Dan Ryan, head of research at the Swiss Re Institute, talks to Cintia Cheong about the rise of genetic testing, life insurtech, and why insurers and academics need to work together to understand mortality trends

NN's Jan-Hendrik Erasmus: "the key issue is how to embrace technology"

NN Group's chief risk officer discusses with David Walker how the Dutch insurer is positioned for M&A, why Solvency II does not need to change, longevity risk hedging and today's technology and cyber challenges

More Longevity/mortality Analysis >